FDA accepts BLA resubmission of pz-cel in recessive dystrophic epidermolysis bullosa and sets PDUFA target action date of ...

This optimism is reflected in the stock’s impressive performance, with shares rising by approximately 350% since the initiation of the Phase 1 study in late April. Moreover ... and Japan by 2037, ...

Industries have been slow to adopt hydrogen power because it currently costs more to produce hydrogen fuel than it does to ...

FDA accepts BLA resubmission of pz-cel in recessive dystrophic epidermolysis bullosa and sets PDUFA target action date of April 29, 2025 Company makes significant progress toward potential commerciali ...

Despite short-term risks, the fundamentals of the economy are robust. Find out my thoughts on what really matters for ...

Major League Soccer faces pressure to shift its season calendar to align with Europe's in order to maximize playoff exposure ...

NTPC Green Energy has announced to launch its initial public offering (IPO) on Tuesday, November 19 and the bidding for the ...

Thailand’s nuclear power plant project is about to make its debut as the Energy Regulatory Commission (ERC) plans to sign a ...

One of the most talked about moments in boxing history will finally be realized on Friday, Nov. 15, 2024, when Mike Tyson vs.

Benin followed in February 2024, selling $750 million of 14-year bonds at an 8.4 percent yield, matching Côte d’Ivoire’s rate ...

The current release of the Y Series Viognier, which enjoys distribution across much of the country ($15 to $24 range), ...

1. Current NAV: The Current Net Asset Value of the Edelweiss CRISIL IBX 50:50 Gilt Plus SDL April 2037 Index Fund - Regular Plan as of Nov 12, 2024 is Rs 12.12 for Growth option of its Regular plan. 2 ...